The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sanomigran 1.5mg Tablets



Phoenix LabsPA1113/012/002

Main Information

Trade NameSanomigran 1.5mg Tablets
Active SubstancesPizotifen
Dosage FormCoated tablet
Licence HolderPhoenix Labs
Licence NumberPA1113/012/002

Group Information

ATC CodeN02CX Other antimigraine preparations
N02CX01 pizotifen

Status

License statusAuthorised
Licence Issued07/09/1994
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back